中国结合医学杂志(英文版)2026,Vol.32Issue(3):204-212,9.DOI:10.1007/s11655-025-3834-9
Efficacy and Safety of Aurantii Fructus Immaturus Flavonoid Tablets in Patients with Functional Dyspepsia:A Multicenter,Randomized,Double-Blind,Placebo-Controlled Phase Ⅲ Clinical Trial
Efficacy and Safety of Aurantii Fructus Immaturus Flavonoid Tablets in Patients with Functional Dyspepsia:A Multicenter,Randomized,Double-Blind,Placebo-Controlled Phase Ⅲ Clinical Trial
YANG Xiao-nan 1XIANG Jin 2GONG Mei 3YU Bin 4ZHOU Zheng-hua 5LI Hui-zhen 6GE Yan 7XIE Jing-ri8
作者信息
- 1. Integrated Traditional Chinese and Western Medicine,West China Hospital of Sichuan University,Chengdu(610441),China
- 2. GCP Center,West China Hospital of Sichuan University,Chengdu(610441),China
- 3. Department of Gastroenterology,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu(610072),China
- 4. Department of Gastroenterology,the First Affiliated Hospital of Hunan University of Chinese Medicine,Changsha(410021),China
- 5. Department of Spleen and Stomach,the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin(300192),China
- 6. Department of Spleen and Stomach,the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin(300150),China
- 7. Department of Gastroenterology,Guangdong Second Hospital of Traditional Chinese Medicine,Guangzhou(510095),China
- 8. Department of Hepatosplenomegaly,the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine,Harbin(150040),China
- 折叠
摘要
关键词
Chinese medicine/Aurantii Fructus Immaturus/functional dyspepsia/phase Ⅲ trial/efficacy/safety/randomized controlled trialKey words
Chinese medicine/Aurantii Fructus Immaturus/functional dyspepsia/phase Ⅲ trial/efficacy/safety/randomized controlled trial引用本文复制引用
YANG Xiao-nan,XIANG Jin,GONG Mei,YU Bin,ZHOU Zheng-hua,LI Hui-zhen,GE Yan,XIE Jing-ri..Efficacy and Safety of Aurantii Fructus Immaturus Flavonoid Tablets in Patients with Functional Dyspepsia:A Multicenter,Randomized,Double-Blind,Placebo-Controlled Phase Ⅲ Clinical Trial[J].中国结合医学杂志(英文版),2026,32(3):204-212,9.